Publications by authors named "Carl Arevang"

Fatty acid esters of hydroxy fatty acids (FAHFAs), a newly discovered class of human endogenous complex lipids showing great promise for treating diabetes and inflammatory diseases, exist naturally in extremely low concentrations. This work reports a chemo-enzymatic approach for the comprehensive synthesis of phospholipids containing FAHFAs via sequential steps: hydratase-catalyzed hydration of unsaturated fatty acids to generate structurally diverse hydroxy fatty acids (HFAs), followed by the selective esterification of these HFAs with fatty acids mediated by secondary alcohol-specific lipase A (CALA), resulting in the formation of a series of diverse FAHFA analogs. The final synthesis is completed through carbodiimide-based coupling of FAHFAs with glycerophosphatidylcholine.

View Article and Find Full Text PDF

A sustainable and green approach was developed for the scalable synthesis of uncommon naturally occurring phospholipid species, Hemi-bis(monoacylglycero)phosphates (Hemi-BMPs) and bis(diacylglycero)phosphates (BDPs) via the phospholipase D (PLD) mediated transphosphatidylation. PLD from . showed great substrate promiscuity for both phospholipids from different biological sources, and alcohol donors with diverse regiochemistry; monoacylglycerols with diverse fatty acyl structures (C12-C22), affording 74-92 wt% yields in 2 h.

View Article and Find Full Text PDF
Article Synopsis
  • Phospholipids are vital molecules in biological systems with unique structures and properties, but natural sources often lack the necessary variety and quantity for applications.
  • This work explores innovative methods for synthesizing and modifying phospholipids, focusing on sustainable approaches through chemo-/enzymatic techniques and genetic engineering.
  • The review also emphasizes the application of green chemistry principles in the production of phospholipids, highlighting the use of eco-friendly biocatalysts and minimizing toxic solvents in the synthesis process.
View Article and Find Full Text PDF

Oral squamous cell carcinoma (OSCC) is the most common cancer affecting the oral cavity, and US clinics will register about 30,000 new patients in 2015. Current treatment modalities include chemotherapy, surgery, and radiotherapy, which often result in astonishing disfigurement. Cancers of the head and neck display enhanced levels of glucose-regulated proteins and translation initiation factors associated with endoplasmic reticulum (ER) stress and the unfolded protein response (UPR).

View Article and Find Full Text PDF
Article Synopsis
  • Proteins with expanded polyglutamine sequences are linked to serious neurodegenerative diseases like Huntington's disease, prompting research into potential treatments.
  • A study screened around 11,000 natural product extracts to find compounds that can counteract polyQ aggregation in yeast, leading to the discovery of actinomycin D as a potent inhibitor.
  • Actinomycin D not only prevents polyQ aggregation in yeast but also boosts levels of protective heat-shock proteins, demonstrating a possible common mechanism in mammalian cells as well and highlighting natural products' potential in developing therapies.
View Article and Find Full Text PDF

Capturing a coactivator, naturally: the natural products sekikaic acid and lobaric acid, isolated after a high-throughput screen of a structurally diverse extract collection, effectively target the dynamic binding interfaces of the GACKIX domain of the coactivator CBP/p300. These molecules are the most effective inhibitors of the GACKIX domain yet described and are uniquely selective for this domain.

View Article and Find Full Text PDF